Results 21 to 30 of about 90,842 (160)

Oral squamous cell carcinoma of tongue: Histological risk assessment. A pilot study [PDF]

, 2019
Background: More than 90% of malignant tumors diagnosed in the oral cavity are Oral Squamous Cell Carcinomas (OSCC) whose preferred location is the tongue.
Cebrián Carretero, José Luis, López Sánchez, Antonio Francisco, Martínez García, Miguel Angel, Migueláñez Medrán, Carmen, Pozo Kreilinger, José Juan   +4 more
core   +3 more sources

Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma

Case Reports in Otolaryngology, 2022
Clinical evaluation, differential diagnosis, and management of a neck mass constitute commonly encountered problems for the head and neck surgeon. An asymptomatic neck mass in adults may be the only clinical sign of head and neck cancer.
Alexander Karatzanis, Kleanthi Mylopotamitaki, Eleni Lagoudaki, Emmanuel Prokopakis, Sofia Agelaki   +4 more
doaj   +1 more source

The current role of salvage surgery in recurrent head and neck squamous cell carcinoma [PDF]

, 2018
Hamoir, M., Schmitz, S., Suarez, C., Strojan, P., Hutcheson, K.A., Rodrigo, J.P., Mendenhall, W.M., Simo, R., Saba, N.F., D‘Cruz, A.K., Haigentz, M., Jr., Bradford, C.R., Genden, E.M., Rinaldo, A., Ferlito ...
Hamoir, M., Rodrigo Tapia, Juan Pablo, Schmitz, S., Suárez Nieto, Carlos   +3 more
core   +2 more sources

Circulating tumor cells in head and neck cancer: A review

World Journal of Otorhinolaryngology-Head and Neck Surgery, 2016
Carcinoma of the head and neck represents 3.5% of all cancers, and the vast majority of these tumors are squamous cell carcinoma (HNSCC). With a stable overall survival rate of 50% among all stages, there is continued interested in developing measures ...
Kyle P. McMullen, Jeffrey J. Chalmers, Jas C. Lang, Pawan Kumar, Kris R. Jatana   +4 more
doaj   +1 more source

Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC). [PDF]

, 2018
The landscape of head and neck squamous cell carcinoma (HNSCC) has been changing rapidly due to growing proportion of HPV-related disease and development of new therapeutic agents.
Jung, Kyungsuk, Kang, Hyunseok, Mehra, Ranee   +2 more
core   +2 more sources

Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma

Tumor Biology, 2017
The aim of this study was to determine the methylation status of the genes encoding the vascular endothelial growth factor receptors and to evaluate the usefulness of VEGFR methylation as a prognostic indicator in head and neck squamous cell carcinoma ...
Yuki Misawa, Kiyoshi Misawa, Hideya Kawasaki, Atsushi Imai, Daiki Mochizuki, Ryuji Ishikawa, Shiori Endo, Masato Mima, Takeharu Kanazawa, Toshihide Iwashita, Hiroyuki Mineta   +10 more
doaj   +1 more source

A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck [PDF]

, 2005
Objective: The purpose of this pilot study was to evaluate the feasibility and toxicity of concurrent chemotherapy with vinorelbine and mitomycin C in combination with accelerated radiotherapy (RT) in patients with locally advanced cancer of the head and
Bernier J, Budach W, Colevas AD, Colleoni M, Conti F, De Placido S, Degardin M, Dische S, Dobrowsky W, Gasparini G, Gralla R, Grau C, Haffty BG, Harrison LB, Hehr T, Kies MS, Koch WM, Munker R, Pouillart P, Poulsen MG, Regine WF, Shin DM, Siu LL, Vici P, Vokes EE, Wendt TG   +25 more
core   +1 more source

Tim-3-expressing macrophages are functionally suppressed and expanded in oral squamous cell carcinoma due to virus-induced Gal-9 expression

Tumor Biology, 2017
Oropharyngeal head and neck squamous cell carcinoma is a common malignant tumor in the oral cavity. High-risk human papillomavirus 16 infection is a major cause of oropharyngeal head and neck squamous cell carcinoma development.
Jianfeng Dong, Lijun Cheng, Minchao Zhao, Xiangfeng Pan, Zhiqiang Feng, Dawei Wang   +5 more
doaj   +1 more source

A composite score based on immune-related gene prognostic index and m6A risk score of head and neck squamous cell carcinoma

Frontiers in Genetics, 2023
Background: Immunotherapy has been demonstrated favorable in head and neck squamous cell carcinoma (HNSCC). Studies indicated that immune-related gene prognostic index (IRGPI) was a robust signature, and N6-methyladenosine (m6A) methylation had a ...
Yizhou Yang, Yizhou Yang, Yizhou Yang, Zeman Cai, Kaichun Huang, Mei Li, Xiao Wang, Xiao Wang, Xiao Wang, Yinbing Lin, Yinbing Lin, Yinbing Lin, Sijie Chen, Sijie Chen, Sijie Chen, Zhining Yang, Zhining Yang, Zhixiong Lin, Zhixiong Lin, Zhixiong Lin   +19 more
doaj   +1 more source

Maintenance of head and neck tumor on-chip: gateway to personalized treatment? [PDF]

, 2017
Aim: Head and neck squamous cell carcinomas (HNSCC) are solid tumors with low overall survival (40–60%). In a move toward personalized medicine, maintenance of tumor biopsies in microfluidic tissue culture devices is being developed. Methodology/ results:
Bower, Ruth, Crank, Stephen T, Green, Victoria L., Greenman, John, Karsai, Laszlo, Kuvshinov, Dmitriy, Kuvshinova, Elena, Stafford, Nicholas D   +7 more
core   +1 more source